Chuangyuan Biotech has reached a strategic cooperation with the Institute of Radiation Medicine, Chinese Academy of Medical Sciences.

On April 19, Tianjin Chuangyuan Biotechnology Co., Ltd. and the Institute of Radiation Medicine of the Chinese Academy of Medical Sciences held a strategic cooperation signing ceremony in Tianjin. Dr. Liang Wu, Director of the Key Laboratory of Edible Probiotics in Tianjin and Chairman of Chuangyuan Biotechnology, signed the agreement with Director Zhou Jiaxi of the Institute of Radiation Medicine of the Chinese Academy of Medical Sciences. Chen Zheng, Deputy Director of the Science and Technology Bureau of Tianjin Binhai New Area, Han Lin, Standing Committee Member of the Party Committee and Deputy Director of the Management Committee of Tianjin Binhai High-tech Zone, Professor Lu Fuping, Director of the Academic Committee, Deputy Secretary of the Party Committee, and President of Tianjin University of Science and Technology, and Professor Zhang Min, Vice President of Tianjin Agricultural University, witnessed the signing ceremony.

Both parties agreed to fully utilize each other's technological platforms, research advantages, and resource advantages to carry out close cooperation in research projects, talent training, achievement transformation, and product development, establish a joint experimental base, create a transformation platform, jointly complete industry-university-research topics, promote the application of probiotics in the biomedical field, accelerate the transfer and transformation of achievements, and the rapid development of related technology industries, helping products achieve transformation and contribute to public health.

In his speech, Dr. Liang Wu stated that the Institute of Radiation Medicine of the Chinese Academy of Medical Sciences is a national-level research institution with very strong research capabilities. The strategic cooperation with the Institute will greatly enhance Chuangyuan's technological innovation capabilities, industrial development process, and market competitiveness. We will actively promote comprehensive cooperation in various models and hope to achieve breakthrough progress in multiple projects. We sincerely thank the Institute for its trust and support, and look forward to our joint efforts to promote the advancement of scientific research and contribute more wisdom and strength to human health and well-being.

Director Zhou Jiaxi expressed gratitude for the support and promotion of the high-tech zone government for this cooperation, and provided a detailed introduction to the background, research and development direction, technical capabilities, and the latest development and transformation ideas of the Institute of Radiation Medicine of the Chinese Academy of Medical Sciences. He also expressed optimism about the development of this cooperation project and the future of functional food development. He hopes to take this signing cooperation as an opportunity to explore more cooperation models and market opportunities with Chuangyuan Biotechnology, jointly develop rehabilitation micro-ecological products, promote achievement transformation, and achieve mutual assistance and win-win results among the government, research institutions, and enterprises.

This cooperation plays an important role in the collaboration between government, research institutions, and enterprises, and is a significant measure for all parties to vigorously explore new development tracks and achieve new breakthroughs. In the future, Chuangyuan Biotechnology will further focus on industry development and market expansion systems, assist in reform and innovation, deepen resource utilization and business integration, expand cooperation in all directions, and create a platform for cooperation and win-win in the Beijing-Tianjin-Hebei region, injecting new vitality into industrial innovation and development.

Zhao Jing, Director of the Biomedical Bureau of Tianjin Binhai High-tech Zone, and Dong Liping, a first-level staff member of the Science and Technology Bureau of Tianjin Binhai High-tech Zone, were invited to attend. Cui Ming, Deputy Director of the Science and Technology Department of the Institute of Radiation Medicine of the Chinese Academy of Medical Sciences, Yu Chengcheng, Deputy Director of the Industry Department, researcher Zhou Xiaoliang, management staff Chen Xue, and members of the Academic Committee of the Key Laboratory of Edible Probiotics in Tianjin participated in this event. Representatives from Chuangyuan Biotechnology's management team and R&D team accompanied them.

Chinese Academy of Medical Sciences Institute of Radiation Medicine, Tianjin Chuangyuan Biotechnology Co., Ltd., Chuangyuan Biology

Chuangyuan Biotechnology has been awarded the status of a council member of the China Anti-Aging Promotion Association.

The unveiling ceremony of the Key Laboratory of Edible Probiotics in Tianjin and the academic exchange conference have concluded successfully.

Chuangyuan Biotechnology has been awarded the status of a council member of the China Anti-Aging Promotion Association.

The unveiling ceremony of the Key Laboratory of Edible Probiotics in Tianjin and the academic exchange conference have concluded successfully.

2024-12-23

In December 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. and Haihe Dairy jointly held a series of themed activities titled "Party Building Mutual Visits and Learning" to further promote the deep integration of both parties' party building work and business development. During the event, both sides will conduct company visits and on-site discussions. Recently, Haihe Dairy made an initial visit and, after gaining a deep understanding of Chuangyuan Biotech's products, expressed high recognition and close attention, laying a solid foundation for future cooperation. Subsequently, both parties engaged in detailed communication on the core topics of "exchange of party building experiences and sharing of business resources," discussing standardized construction of party branches, distinctive party building measures, and the promotion of party-business integration. They also conducted in-depth exchanges on aspects such as corporate cooperation, product intercommunication, and information sharing, jointly exploring new paths for the development of the health industry under the guidance of party building, providing more possibilities for further establishing a "symbiotic, mutually promoting, and win-win" cooperative relationship. Both parties hope to achieve industrial resonance through party building leadership and contribute to the development of the health industry in the Binhai New Area.

Strength crowned, Chuangyuan Biotechnology won two Science and Technology Awards from the China Food Industry Association.

2024-12-17

On December 16, 2024, the 22nd China Food Safety Conference and the 2024 National Food Industry Science and Technology Progress Conference, themed "Implementing Food Safety Strategy to Support the Construction of a Healthy China," was grandly held in Beijing. During the conference, the award ceremony for the 2024 National Food Industry Science and Technology Progress Conference was also held. Tianjin Chuangyuan Biotechnology Co., Ltd. won the second prize for scientific and technological progress in the "2023 China Food Industry Association Science and Technology Award" for two projects: "Key Technology Breakthrough and Industrial Application of New Postbiotics Segmented Solid-State Fermentation" and "Development and Application of Key Technologies and Equipment for Plant Polysaccharide Efficacy Verification and Extraction."

Chuangyuan Biotech's lactic acid bacteria IOB701 post-fermentation probiotic powder has been granted a national invention patent.

2024-12-13

On December 13, 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. received an invention patent certificate from the National Intellectual Property Administration for its independently developed and filed method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder (Patent No.: ZL 202411354886.X). This invention provides a method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder, which relates to the field of microbiology. The Lactobacillus plantarum IOB701 was preserved on July 10, 2018, at the General Microbial Culture Collection Center of the China Microbial Strain Preservation Management Committee, abbreviated as CGMCC, with the preservation address at No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number CGMCC No. 16077. Using grains or legumes treated with low oxygen stress as the fermentation substrate, the Lactobacillus plantarum IOB701 fermentation resulted in postbiotics powder, which, according to animal experiments, has been shown to improve chronic unpredictable mild stress-induced depressive-like behavior in mice.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Jin Gong Wang An Bei No. 12019202000539

Business License